Follow-up: Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Author:

Patent Attorney
European Patent Attorney
Of Counsel

As a follow-up to our IP newsletter of July 12, 2017, here is an English translation of the decision of the Federal Supreme Court/Federal Court of Justice and the original German decision for your convenience. Again, our Munich partner Fritz Lahrtz would be happy to answer any questions you may have if possible in view of the confidential parts of the case.

More articles from Dr. Raphael Bösl

18 10 18

The “Druckexemplar” determines the extent of protection conferred by a European patent

Dr. Raphael Bösl

17 08 18

Restoration of the Right of Priority under the PCT – different “Criterion for Restoration” before the USPTO and the EPO

Dr. Raphael Bösl

09 05 18

License Fees for a Compulsory License – Isentress II – German Federal Patent Court

Dr. Raphael Bösl

31 08 17

Follow-up: Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

12 07 17

Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

04 07 17

EPO clarifies practice in the area of plant and animal patents

Dr. Raphael Bösl

13 02 17

Urgent Notice of the Federal Patent Court: Preliminary Injunction issued in a Compulsory License Proceedings concerning “Isentress” (raltegravir against AIDS)

Dr. Raphael Bösl

22 12 16

EPO stays all proceedings in which the invention is a plant or animal obtained by an essentially biological process

Dr. Raphael Bösl

27 07 16

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent of July 1, 2016

Dr. Raphael Bösl

17 02 16

Functional Features – Essential Features: A New Perspective under Article 84 EPC

Dr. Raphael Bösl

11 09 15

Plant Patent Protection and Plant Variety Protection – Two Independent IP Rights?

Dr. Raphael Bösl

21 08 15

A pitfall to supplement information incorporated by reference under the EPC

Dr. Raphael Bösl

30 06 15

EPO: claims directed to the use of a product produced by a process

Dr. Raphael Bösl

27 03 15

Enlarged Board of Appeal of the EPO decided on Clarity – expected decision now issued (G 3/14)

Dr. Raphael Bösl

07 11 14

Deautomation is not per se Inventive – an Exemption from the Rule under the EPC

Dr. Raphael Bösl

12 09 14

Four Step Approach in Determining Sufficiency of Disclosure of a Parameter under the EPC

Dr. Raphael Bösl

04 07 14

Refocus on the Interpretation of “Undue Burden” for the Determination of the Scope of Protection under the EPC

Dr. Raphael Bösl

10 01 14

Functional Definition of Compounds in Use Claims – Different Decisions in Germany and “Europe”

Dr. Raphael Bösl

All articles